Vivani Medical, Inc. (VANI)
NASDAQ: VANI · Real-Time Price · USD
1.360
-0.020 (-1.45%)
At close: Aug 6, 2026, 4:00 PM EDT
1.371
+0.011 (0.78%)
After-hours: Aug 6, 2026, 7:34 PM EDT
Vivani Medical Employees
Vivani Medical had 42 employees as of December 31, 2025. The number of employees increased by 5 or 13.51% compared to the previous year.
Employees
42
Change (1Y)
5
Growth (1Y)
13.51%
Revenue / Employee
n/a
Profits / Employee
-$644,929
Market Cap
117.28M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 42 | 5 | 13.51% |
| Dec 31, 2024 | 37 | -7 | -15.91% |
| Dec 31, 2023 | 44 | -6 | -12.00% |
| Dec 31, 2022 | 50 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Codexis | 146 |
| Nautilus Biotechnology | 127 |
| Seer, Inc. | 124 |
| enGene Therapeutics | 82 |
| Connect Biopharma Holdings | 64 |
| Genelux | 26 |
| Spruce Biosciences | 14 |
| ProMIS Neurosciences | 11 |
VANI News
- 10 hours ago - Vivani Medical announces full enrollment, initial dosing in SLIM-1 trial - TheFly
- 12 hours ago - Vivani Medical Announces Successful Dosing of All Participants in SLIM-1, a Phase 1 Trial Evaluating NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management - GlobeNewsWire
- 22 days ago - Vivani Medical Transcript: Emerging Growth Conference - Transcripts
- 23 days ago - Vivani Medical to Present at the Emerging Growth Conference on July 15, 2026 - GlobeNewsWire
- 26 days ago - A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss - CNBC
- 4 weeks ago - Vivani Medical enters pact with Novo Nordisk to evaluate NPM-139 - TheFly
- 4 weeks ago - Vivani Medical Enters into Agreement with Novo Nordisk to Evaluate NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management - GlobeNewsWire
- 4 weeks ago - Vivani Medical Slides: Corporate presentation - Filings